These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Amiodarone: treatment or cause of atrial fibrillation?]. Allali G; Falconnet C Rev Med Suisse; 2005 Nov; 1(39):2533-5. PubMed ID: 16323735 [TBL] [Abstract][Full Text] [Related]
45. [Selective pituitary resistance to thyroid hormone in a patient treated with amiodarone]. Gómez JJ; Pomar MD; Casariego AV; Rodríguez IC Endocrinol Nutr; 2009 Oct; 56(8):418-21. PubMed ID: 19959152 [TBL] [Abstract][Full Text] [Related]
47. Incidence of amiodarone-induced thyroid dysfunction and predictive factors for their occurrence. Aleksić Z; Aleksić A Med Pregl; 2011; 64(11-12):533-8. PubMed ID: 22368995 [TBL] [Abstract][Full Text] [Related]
48. Amiodarone-induced thyroid dysfunction--clinical picture. Study on 215 cases. Preda C; Aprotosoaie AC; Petris A; Costache II Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):359-63. PubMed ID: 25076700 [TBL] [Abstract][Full Text] [Related]
49. Amiodarone therapy before heart transplantation as a predictor of thyroid dysfunction after transplantation. Siccama R; Balk AH; de Herder WW; van Domburg R; Vantrimpont P; van Gelder T J Heart Lung Transplant; 2003 Aug; 22(8):857-61. PubMed ID: 12909464 [TBL] [Abstract][Full Text] [Related]
50. Thyroid dysfunction and cardiological management in patients receiving amiodarone. Fuks AG; Vaisman M; Buescu A Arq Bras Cardiol; 2004 Jun; 82(6):523-32. PubMed ID: 15257370 [TBL] [Abstract][Full Text] [Related]
51. [Amiodarone-induced thyrotoxicosis: case report and review of the literature]. Bianconcini M; Giannini AL Ital Heart J Suppl; 2003 Aug; 4(8):682-7. PubMed ID: 14655464 [TBL] [Abstract][Full Text] [Related]
53. [Amiodarone and the thyroid]. Pavan R; Jesus AM; Maciel LM Arq Bras Endocrinol Metabol; 2004 Feb; 48(1):176-82. PubMed ID: 15611831 [TBL] [Abstract][Full Text] [Related]
54. Amiodarone-Induced thyroid dysfunction and ventricular tachyarrhythmias during long-term therapy in Japan. Shiga T; Wakaumi M; Matsuda N; Shoda M; Hagiwara N; Sato K; Kasanuki H Jpn Circ J; 2001 Nov; 65(11):958-60. PubMed ID: 11716246 [TBL] [Abstract][Full Text] [Related]
55. Amiodarone-induced dysthyroidism. Pitfalls and management. Leenhardt L J Med Liban; 1995; 43(3):148-9. PubMed ID: 8885546 [No Abstract] [Full Text] [Related]
56. [Incidence of thyroid dysfunction in patients during chronic treatment with amiodarone]. Valenzuela MA; Bianchi C; Pineda G; Meruane J Rev Med Chil; 1985 Nov; 113(11):1072-5. PubMed ID: 3837294 [No Abstract] [Full Text] [Related]
57. Diagnosis and Clinical Course of Three Adolescents with Amiodarone-Induced Hyperthyroidism. Gesing J; Hoppmann J; Gebauer R; Pfäffle R; Bertsche A; Kiess W Pediatr Cardiol; 2018 Dec; 39(8):1707-1716. PubMed ID: 30242442 [TBL] [Abstract][Full Text] [Related]
58. [Thyroid function and amiodarone. Consequences on dysthyroidism testing]. Fragu P; Schlumberger M Ann Cardiol Angeiol (Paris); 1985 Jan; 34(1):5-10. PubMed ID: 3883881 [TBL] [Abstract][Full Text] [Related]
59. Impact of thyroid metabolism on the course of INR levels in a patient with systemic anticoagulation suffering from amiodarone-induced thyrotoxicosis. Bucerius J; Ezziddin S; Brockmann H; Palmedo H; Biersack HJ Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):606-9. PubMed ID: 17943696 [TBL] [Abstract][Full Text] [Related]
60. Radioiodine ablation of the thyroid to allow the reintroduction of amiodarone treatment in patients with a prior history of amiodarone-induced thyrotoxicosis. Hermida JS; Jarry G; Tcheng E; Moullart V; Arlot S; Rey JL; Delonca J; Schvartz C Am J Med; 2004 Mar; 116(5):345-8. PubMed ID: 14984821 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]